Shawn Egan

Stock Analyst at Citigroup

(2.01)
# 2,943
Out of 4,884 analysts
5
Total ratings
100%
Success rate
2.06%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Shawn Egan

Arrowhead Pharmaceuticals
May 13, 2025
Maintains: Neutral
Price Target: $21$17
Current: $16.79
Upside: +1.25%